文献速递肾癌与肾肿瘤

转移灶组织病理学对手术切除的转移性肾细胞癌患者肿瘤学结局的影响

The Impact of Metastasis Histopathology on Oncologic Outcomes for Patients With Surgically Resected Metastatic Renal Cell Carcinoma.
PubMed 文献 · J Urol · 2023-06-20

该研究纳入266例1970至2019年间行肾切除术且单发转移灶完全切除的转移性透明细胞肾细胞癌患者,比较仅用转移灶特征、用原发肿瘤特征及用转移灶特征计算的Leibovich评分对癌症特异性生存的预测能力,发现基于转移灶组织病理学的评分算法可用于预测癌症特异性生存。

要点

  • 使用转移灶分级和坏死计算的Leibovich评分(c=0.679)与使用原发肿瘤分级和坏死的原始评分(c=0.675)预测能力相似。
  • 仅含转移灶特征的第三模型(c=0.707)显示肾切除后2年内转移灶切除、骨转移、高级别和肉瘤样分化与癌症特异性生存显著相关。
  • 基于转移灶组织病理学的评分算法可用于预测手术切除的转移性透明细胞肾细胞癌患者的癌症特异性生存。

核心结论

  • 使用转移灶组织病理学特征计算的评分算法可用于预测手术切除的转移性透明细胞肾细胞癌患者的癌症特异性生存,尤其当原发肿瘤组织病理学不易获得时具有重要意义。

研究设计与样本

  • 研究纳入266例1970至2019年间行肾切除术且单发转移灶完全切除的转移性透明细胞肾细胞癌患者。
  • 比较三种模型:使用原发肿瘤分级和坏死的Leibovich评分、使用转移灶分级和坏死的Leibovich评分、仅含转移灶特征的第三模型,采用Cox比例风险模型的c指数比较预测能力。

主要发现

  • 197例患者死于肾细胞癌,中位时间2.3年(IQR 1.1-4.5);幸存者中位随访13.2年(IQR 10.0-14.5)。
  • 使用转移灶分级和坏死的Leibovich评分(c=0.679)与使用原发肿瘤分级和坏死的原始Leibovich评分(c=0.675)预测能力相似。
  • 第三模型(c=0.707)显示肾切除后2年内转移灶切除、骨转移、高级别和转移灶肉瘤样分化与癌症特异性生存显著相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Multiple prognostic models exist to assess survival among patients with metastatic clear cell renal cell carcinoma. However, the relative contribution of histopathological features of the metastasis has not been extensively studied. Herein, we compared models using clinical, primary tumor, and metastatic features to predict cancer-specific survival for patients with surgically resected metastatic clear cell renal cell carcinoma. MATERIALS AND METHODS: We studied 266 patients who had undergone nephrectomy between 1970 and 2019, and who had a single site of metastasis completely resected. Two versions of the metastatic clear cell renal cell carcinoma score published by Leibovich et al were calculated, using grade and necrosis from the primary tumor and using grade and necrosis from the metastasis. Predictive abilities of these 2 versions and a third model that included metastatic features only were compared using c-indexes from Cox proportional hazards models. RESULTS: A total of 197 patients died from renal cell carcinoma at a median of 2.3 years (IQR 1.1-4.5); median follow-up among survivors was 13.2 years (IQR 10.0-14.5). The Leibovich score using grade and necrosis from the metastasis (c=0.679) had similar predictive ability compared to the original Leibovich score using grade and necrosis from the primary tumor (c=0.675). A third model (c=0.707) demonstrated that metastasectomy within 2 years after nephrectomy, presence of bone metastasis, high grade, and sarcomatoid differentiation in the metastasis were significantly associated with cancer-specific survival. CONCLUSIONS: Scoring algorithms calculated using histopathological features of the metastasis can be used to predict cancer-specific survival for patients with surgically resected metastatic clear cell renal cell carcinoma. These findings are of particular importance for instances when primary tumor histopathology is not readily available.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Pessoa RR, Nabavizadeh R, Quevedo F, et al. The Impact of Metastasis Histopathology on Oncologic Outcomes for Patients With Surgically Resected Metastatic Renal Cell Carcinoma. J Urol. 2023. PMID: 37338930. doi:10.1097/JU.0000000000003601

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。